Khavanin Zadeh Morteza, Omrani Zahra, Cheraghali Roozbeh, Hashemaghaee Mehdi
Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran.
Rasool Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Med J Islam Repub Iran. 2021 Sep 28;35:125. doi: 10.47176/mjiri.35.125. eCollection 2021.
The survival of arteriovenous fistula (AVF) remains an important problem for hemodialysis patients, accounting for 20% of all hospitalizations related to AV access problems in western countries. We designed an observational prospective cohort study on 265 AVFs and evaluated their results after 4 months of fistula creation and its relation to laboratory tests as ESR and CRP levels. Wrist or antecubital AVFs were created for patients with End-Stage renal disease. All laboratory tests (ESR and CRP) were checked quantitatively. The patients were followed-upfor at least 4 months and failure or maturation of AVFs were recorded in a checklist. 177 (66.8%) males and 88 (33.2%) females were included. The surgeon created 161(60.8%) wrist and 98 (37%) antecubital AVFs. The mean age of patients was 53.18±17.1, ranged from 8 to 91 years old. CRP and total protein had significant differences between the two groups of failure and mature accesses (0.029 and 0.045 respectively). High CRP level is recognized as a reliable predictor for the survival of AVF.
动静脉内瘘(AVF)的存活仍然是血液透析患者面临的一个重要问题,在西方国家,这一问题占所有与动静脉通路问题相关住院病例的20%。我们针对265个动静脉内瘘设计了一项前瞻性观察队列研究,并在造瘘4个月后评估其结果,以及它与血沉(ESR)和C反应蛋白(CRP)水平等实验室检查结果之间的关系。为终末期肾病患者创建腕部或肘前动静脉内瘘。所有实验室检查(ESR和CRP)均进行定量检测。对患者进行至少4个月的随访,并将动静脉内瘘的失败或成熟情况记录在检查表中。纳入177名男性(66.8%)和88名女性(33.2%)。外科医生创建了161个(60.8%)腕部动静脉内瘘和98个(37%)肘前动静脉内瘘。患者的平均年龄为53.18±17.1岁,年龄范围为8至91岁。CRP和总蛋白在失败组和成熟通路组之间存在显著差异(分别为0.029和0.045)。高CRP水平被认为是动静脉内瘘存活的可靠预测指标。